Food & Health

Regenxbio Shares Plunge Amid Clinical Hold Setback

RGX-121 trial halt impacts Regenxbio's valuation, highlighting sector risks with spinal nodules discovery.

August 24, 20263 min read

Sector Watch

Food & Health

Regeneron climbs 4% with Pasatru's FDA nod, enhancing its foothold in orphan-drug market with premium pricing potential.

Aug 203 min read

Energy

Oil prices climb as the UAE-Iran rift and Hormuz blockade tighten global supply. Market reacts to sector implications and valuation impact.

Aug 203 min read

Finance

Luxury homebuilder sees 10% dip in deliveries as market pressures threaten valuation and sector dynamics shift.

Aug 193 min read

Food & Health

Explore JBS's offer for remaining Pilgrim's Pride shares, focusing on deal terms and valuation impact on investors.

Aug 193 min read

Food & Health

RGX-121 trial halt impacts Regenxbio's valuation, highlighting sector risks with spinal nodules discovery.

Aug 243 min read

Food & Health

Patent ruling forces costly royalties on Guardant, affecting its market growth and revenue projections significantly.

Aug 243 min read

Finance

PDD's Q2 net profit drops 12% amid tariff issues and price wars, highlighting significant challenges in sustaining valuation.

Aug 244 min read

Finance

Shein allocates $3.5B to investors as valuation drops 72% since 2022, impacting deal terms and sector dynamics.

Aug 244 min read